Huntington's Disease Research

Huntington's disease is a neurodegenerative disease characterized by cognitive decline and motor dysfunction. It is a genetic disorder which results in the production of mutant huntingtin protein (mHtt). This protein aggregates in the cell cytoplasm and nucleus, affecting cellular function.

Huntington's Disease Research Products Targets

Products for Huntington's Disease Research - Page 24

Cat.No. Product Name Information/Activity
BCC6552 DL-AP5 76326-31-3
BCC6554 L-AP5 79055-67-7
BCC6551 DL-AP7 78966-69-5
BCC6631 Arcaine sulfate 14923-17-2
BCC6602 (R)-4-Carboxyphenylglycine 134052-68-9
BCC7078 CGP 37849 CGP 37849 is a potent, competitive and orally active N-methyl-D-aspartate (NMDA) receptor antagonist. CGP 37849 is an anticonvulsant in rodents and has antidepressant and anxiolytic-like effects.
BCC7053 CGP 39551 127910-32-1
BCC7087 CGP 78608 hydrochloride CGP 78608 hydrochloride is a highly potent and selective antagonist at the glycine-binding site of the NMDA receptor, with an IC50 of 6 nM. CGP 78608 acts as a potentiator of GluN1/GluN3A-mediated glycine currents, with an estimated EC50 in the low nM range (26.3 nM). Anticonvulsant activity.
BCC6986 CGS 19755 110347-85-8
BCC6805 (2R,3S)-Chlorpheg 140924-23-8